Streptococcus agalactiae

Neonatal Infection (Classic Role)#

S. agalactiae colonizes the lower genital tract and rectum in 10–30% of pregnant women (depending on geography and ethnicity; Verani et al. 2010 CDC guidelines). During vaginal delivery, newborns are exposed to GBS in amniotic fluid or birth canal secretions.

If mother is colonized and infant is not treated with intrapartum antibiotic prophylaxis (IAP). Early-onset GBS (EOB) disease: Occurs in 1–2 per 1000 live births (pre-IAP era; now <0.5/1000 with universal screening + penicillin G prophylaxis; Verani et al. 2010 CDC; Schrag et al.

2000 NEJM).

Neonatal sepsis: Fever, hypotension, multi-organ failure within 24 hours of birth. Neonatal meningitis: Occurs in 5–10% of EOB cases; 15–30% mortality despite antibiotics; neurologic sequelae in 30–50% of survivors (Libster et al. 2012 Pediatrics).

Risk factors: Prematurity (<37 weeks), maternal GBS bacteriuria, prolonged rupture of membranes (>18 hours), maternal fever, low birth weight (Schrag et al. 2002 NEJM).

Gynecologic and Endometriosis Context#

Less clinically recognized, but epidemiologically relevant. S. agalactiae is enriched in the reproductive tract microbiota of endometriosis patients (;^{[1]The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy ControlsAta B, Yildiz S, Turkgeldi E et al. · 2019Open reference 1 ↓};^{[2]Microbiota composition and distribution along the female reproductive tract of women with endometriosisWei W, Zhang X, Tang H et al. · 2020Open reference 2 ↓[3]Microbiome of the lower genital tract in Chinese women with endometriosis by 16s-rRNA sequencing technique: a pilot studyChen S, Gu Z, Zhang W et al. · 2020Open reference 3 ↓}).

Hypothesis: Ascended S. agalactiae (from lower genital tract to uterus/fallopian tubes) via dysbiotic-state facilitation. Role in endometriosis: Chronic inflammation, dysbiotic dysbiosis, and estrogen recirculation (via beta-glucuronidase) may promote ectopic endometrial growth and pain. Not the sole cause, but a contributing dysbiotic driver.

Zinc Acquisition#

S. agalactiae encodes zinc transporters (ZnuA, ZnuB homologs; zinc ABC transporters). Competes with host metal-binding proteins (lactoferrin, transferrin, metallothioneins). Elevated hepcidin (iron-withholding) and elevated calprotectin/lactoferrin (zinc-withholding as part of nutritional immunity) suppress GBS growth.

Conversely, zinc supplementation can increase GBS burden in dysbiotic patients.

Role in Endometriosis#

The estrobolome hypothesis posits that dysbiotic β-glucuronidase-dominant microbiota (enriched in S. agalactiae, Bacteroides fragilis, and other deconjugators) drives.

Estrogen recirculation: 50–60% of circulating estradiol undergoes hepatic conjugation daily; dysbiotic reabsorption increases E2 level by 5–15%. Ectopic endometrial proliferation: Elevated E2 stimulates estrogen receptor α (ERα) in ectopic endometrial foci, promoting tissue growth and angiogenesis.

Chronic inflammation: GBS-produced β-glucuronidase is co-produced with pro-inflammatory metabolites; local chronic inflammatory environment enables ectopic endometrial survival. Dysbiotic feedback loop: Elevated estrogen → dysbiotic shift toward β-glucuronidase producers (including GBS) → further estrogen recirculation.

This makes GBS a key driver in the estrobolome-endometriosis axis, though it is one of several β-glucuronidase-producing taxa.

Manganese-Dependent Superoxide Dismutase (Mn-SOD)#

S. agalactiae produces manganese (Mn)-superoxide dismutase (MnSOD; also called manganese-dependent SOD) for antioxidant defense (^{[4]Metal Homeostasis in Pathogenic StreptococciAkbari MS, Doran KS, Burcham LR · 2022Open reference 4 ↓}).

MnSOD is essential for intracellular survival within macrophages and neutrophils (where ROS is the primary killing mechanism) (^{[5]Goh 2024 — An Opportunistic Pathogen Under Stress: How Group B Streptococcus Responds to Cytotoxic Reactive Species and Conditions of Metal Ion Imbalance to SurviveKelvin G K Goh, Devika Desai, Ruby Thapa et al. · 2024Open reference 5 ↓}).

Manganese deficiency impairs MnSOD synthesis → weakened intracellular survival → easier clearance by phagocytes (^{[5]Goh 2024 — An Opportunistic Pathogen Under Stress: How Group B Streptococcus Responds to Cytotoxic Reactive Species and Conditions of Metal Ion Imbalance to SurviveKelvin G K Goh, Devika Desai, Ruby Thapa et al. · 2024Open reference 5 ↓}).

Iron-Dependent Enzymes#

Non-heme iron enzymes: Ribonucleotide reductase (DNA synthesis), cytochromes (energy metabolism). S. agalactiae encodes iron transporters and can scavenge heme iron from hemoglobin-haptoglobin. Iron-dependent growth is less critical than zinc for GBS virulence, but still important for biofilm formation and intracellular persistence.

Biofilm Architecture#

S. agalactiae forms robust biofilms on. Reproductive tissues: Fallopian tube epithelium, endometrial surface (especially in endometriosis lesions). Gastrointestinal epithelium: Colon; associated with dysbiosis and inflammation.

Urinary tract: Bladder epithelium; asymptomatic bacteriuria in some women.

Biofilm polysaccharide matrix contains:

The mimicry of host hyaluronic acid is particularly clever: the bacterial GBC is nearly identical to mammalian cartilage hyaluronic acid, making the immune system unable to distinguish GBS from self. This enables prolonged biofilm persistence with minimal immune clearance.

Intracellular Invasion and Persistence#

S. agalactiae can invade non-professional phagocytes (epithelial cells, trophoblasts). Employs β-hemolysin/cytolysin (CAMP factor) to create pores in cell membranes, enabling internalization. Survives intracellularly in vacuoles; avoids lysosomes (exact mechanism unclear).

Can "hide" from antibiotics and immune cells for weeks to months.

This intracellular niche is especially relevant in chronic endometriosis (persistent dysbiotic infection) and recurrent neonatal infection (if newborn survives initial GBS infection and develops carrier state).

Neonatal GBS (Well-Established)#

Early-onset disease (EOB): Sepsis, meningitis within 24–48 hours; 3–6% mortality (modern management). Late-onset disease (LOB): Occurs at 7–90 days; often meningitis; source may be vertical transmission or environmental acquisition.

Risk factors for invasive disease: Prematurity, prolonged rupture of membranes, maternal fever, low Apgar score, male sex (males 2–3× higher risk than females).

Maternal Complications#

Chorioamnionitis: GBS ascending infection → amniotic fluid infection → fever, preterm labor. Puerperal fever: Postpartum endometritis or sepsis (rare, <0.5% of pregnant women; more common if GBS bacteriuria or colonization).

Urinary tract infection (UTI) and asymptomatic bacteriuria (ASB): 5–10% of pregnant women with GBS ASB; 25% risk of pyelonephritis if untreated.

Endometriosis (Emerging Association)#

Enriched in reproductive tract microbiota: GBS abundance correlates with endometriosis severity score (;^{[1]The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy ControlsAta B, Yildiz S, Turkgeldi E et al. · 2019Open reference 1 ↓[2]Microbiota composition and distribution along the female reproductive tract of women with endometriosisWei W, Zhang X, Tang H et al. · 2020Open reference 2 ↓}).

Elevated in peritoneal fluid: In some endometriosis patients with active peritoneal inflammation (^{[3]Microbiome of the lower genital tract in Chinese women with endometriosis by 16s-rRNA sequencing technique: a pilot studyChen S, Gu Z, Zhang W et al. · 2020Open reference 3 ↓}). Estrogen-responsive dysbiosis: GBS β-glucuronidase activity amplifies estrogen recirculation, promoting disease progression. Pain phenotype: Elevated GBS associated with higher dysmenorrhea and pelvic pain severity scores.

Other Conditions#

Urinary tract infection: GBS is a less common uropathogen than E. coli, but can cause acute cystitis and pyelonephritis. Acute bacterial meningitis (non-neonatal): In elderly (>65) and immunocompromised; 15–30% mortality. Infective endocarditis: Rare; usually in patients with pre-existing valve disease (prosthetic valves, rheumatic disease).

Molecular Methods#

16S rRNA gene sequencing: Streptococcus agalactiae-specific primers; genus-level Streptococcus detection common; species-level differentiation requires careful design or additional markers. Lancefield typing: Latex agglutination with Group B antiserum (classic clinical method); identifies GBS among Streptococcus spp. MALDI-TOF mass spectrometry: Rapid species identification; increasingly used in clinical labs.

qPCR: Species-specific 16S assays; typical range in dysbiotic gut: 10^5–10^8 copies/g feces.

Culture-Based Methods#

Beta-hemolytic growth: S. agalactiae produces β-hemolysis (complete RBC lysis) on blood agar; distinguishes from α-hemolytic (green discoloration) Streptococcus spp. CAMP test: CAMP factor (β-hemolysin) + Staphylococcus aureus phage lysin → enhanced hemolysis; specific for GBS. PYR test: Positive (unlike most Streptococcus spp.); rapid presumptive identification.

Clinical Screening (Pregnancy)#

Vaginal/rectal swab culture: Taken at 35–37 weeks gestation; gold standard for identifying maternal colonization. Enrichment broth: Swabs placed in selective medium (e.g., Todd-Hewitt broth + antibiotics); improves sensitivity. Rapid molecular tests: PCR-based GBS detection; results in <1 hour; increasingly replacing culture in some settings.

Zinc and Endometriosis Intervention Implications (Cureva Layer)#

Though not covered in WikiBiome entity pages, practitioners note. Zinc supplementation: Paradoxically, may increase GBS burden in dysbiotic endometriosis; recommend only if zinc-replete (serum zinc >70 µg/dL). Zinc restriction (in context of dysbiotic endometriosis with elevated GBS): May suppress GBS metallopeptidase activity and reduce inflammation.

Estrogen-restriction: Low-estrogen diet (reduced aromatizable substrates) + estrogen receptor antagonists (e.g., aromatase inhibitors) reduce GBS's dysbiotic advantage. Probiotic restoration: Lactobacillus spp. produce bacteriocins and lactic acid; can suppress GBS in reproductive microbiota.

Streptococcus agalactiae represents a dual-context pathobiont: a major neonatal pathogen requiring prevention via maternal screening and intrapartum antibiotic prophylaxis, and an emerging driver of dysbiotic endometriosis through estrogen recirculation and chronic inflammation.